Epoetin delta (Shire)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin delta (Shire)
Drug Alias Name促红细胞生成素红细胞生成刺激剂红细胞生成素DynepoMDL-104396 +[6
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoiesis stimulants
TargetsNot applicable
Therapy Area/IndicationsAnemiaKidney Failure, Chronic
Global Approved IndicationsAnemiaKidney Failure, Chronic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2002/03/17
Country/TerritoryEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofiShire
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnemiaKidney Failure, Chronic

Other Information

ATC CodeB03XA01
Related LinksWikipediaKEGG